Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner, has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors to now include additional lots distributed in the U.S. and other markets in consultation with the U.S. Food and Drug Administration (FDA).
Lots Effected by Recall
The recall impacts certain lots of the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. None of the recalled lots include the authorized generic for EpiPen Auto-Injector, which is also manufactured by Meridian Medical Technologies.
The manufacturer will be replacing the recalled devices at no cost.
Please visit Mylan’s website to read the Press Release with a list of the impacted lots that were sold in the United States and additional information on how to return effected devices.